Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4271)	3/14/2000 8:49:00 AM
From: PaulW	Read Replies (1) of 10280

Peter: As always I appreciate your thoughts and if you could comment on the following it would be appreciated: biz.yahoo.com Tuesday March 14, 7:30 am Eastern Time Company Press Release SOURCE: Eli Lilly and Company Lilly Files New Drug Application for Once-Weekly Formulation of Fluoxetine Hydrochloride INDIANAPOLIS, March 14 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY - news) filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for a unique once-weekly formulation of Prozac© (fluoxetine hydrochloride) for the treatment of depression. If approved by the FDA, Prozac will be the first and only antidepressant available in a once-weekly formulation. <more> Thanks in advance, Paul

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next